[1] |
GASBARRINI G,RACCO S,FRANCESCHI F,et al.Helicobacter pylori infection: from gastric to systemic disease[J]. Recenti Prog Med,2010,101(1): 27-33.
|
[2] |
刘兵荣, 肖瑾,陈伟,等. 幽门螺杆菌感染与脑梗死患者颈动脉粥样硬化斑块稳定性的关系[J].中国脑血管病杂志,2013,10(5):264-267.
|
[3] |
VIZZARDI E, BONADEI I, PIOVANELLI B, et al.Helicobacter pylori and ischemic heart disease[J]. Panminerva Med, 2011,53(3): 193-202.
|
[4] |
江丽霞,钟星明,施少华,等. 脑梗死患者血清同型半胱氨酸和脂蛋白(a)的变化[J].检验医学,2013,28(10) :954-955.
|
[5] |
常娜,鲁广秀,张建磊. 同型半胱氨酸与动脉粥样硬化型急性脑梗死患者颈动脉粥样硬化的相关性[J].实用医学杂志,2013,29(1):69-70.
|
[6] |
SCHROECKSNADEL K,FRICK B,WIRLEITNER B.Moderate hyperhomocysteinemia and immune activation[J].Curr Pharm Biotechnol,2004,5(1):107-118.
|
[7] |
邓红亮,元小冬,申健,等. 经颅多普勒超声对颈动脉不稳定性斑块危险程度的预测价值[J]. 中国脑血管病杂志, 2011,8(10): 526-529.
|
[8] |
中国肥胖问题工作组.中国成人超重与肥胖症预防与控制指南(节选)[J].营养学报,2004,26(1):1-4.
|
[9] |
中国成人血脂异常防治指南制订联合委员会.中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419.
|
[10] |
王国戗,杨彩玲,郭丽娟. 不同血压水平人群血管危险因子检测及其临床意义探讨[J].检验医学,2014,29(3):254-257.
|
[11] |
AKBAS HS, BASYIGIT S, SULEYMANLAR I, et al.The assessment of carotid intima media thickness and serum paraoxonase-1 activity in Helicobacter pylori positive subjects[J]. Lipids Health Dis,2010,9:92.
|
[12] |
王怡,李永新,王海玲,等.高频超声对高血压前期人群颈动脉内-中膜厚度及斑块形成的检测[J].中华健康管理学杂志,2014,8(1): 51-54.
|
[13] |
MUHLESTEIN JB.Bacterial infections and atherosclerosis[J].J Investig Med,1998,46(8) : 396-402.
|
[14] |
SUNG JJ, SANDERSON JE.Hyperhomocystein-aemia, Helicobacter pylori and coronary heart disease[J].Heart,1996,76(4):305-307.
|
[15] |
ALÉSSIO AC,SANTOS CX,DEBBAS V,et al.Evaluation of mild hyperhomocysteinemia during the development of atherosclerosis in apolipoprotein E-deficient and normal mice[J].Exp Mol Pathol,2011,90(1):45-50.
|
[16] |
ZHANG D,CHEN Y,XIE X,et al.Homocysteine activates vascular smooth muscle cells by DNA demethylation of platelet-derived growth factor in endothelial cells[J]. J Mol Cell Cardiol,2012,53(4):487-496.
|